1. Home
  2. TCRX vs SNT Comparison

TCRX vs SNT Comparison

Compare TCRX & SNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • SNT
  • Stock Information
  • Founded
  • TCRX 2018
  • SNT 1965
  • Country
  • TCRX United States
  • SNT Canada
  • Employees
  • TCRX N/A
  • SNT N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • SNT Telecommunications Equipment
  • Sector
  • TCRX Health Care
  • SNT Telecommunications
  • Exchange
  • TCRX Nasdaq
  • SNT Nasdaq
  • Market Cap
  • TCRX 91.7M
  • SNT 95.2M
  • IPO Year
  • TCRX 2021
  • SNT 1993
  • Fundamental
  • Price
  • TCRX $1.79
  • SNT $4.39
  • Analyst Decision
  • TCRX Strong Buy
  • SNT
  • Analyst Count
  • TCRX 6
  • SNT 0
  • Target Price
  • TCRX $9.50
  • SNT N/A
  • AVG Volume (30 Days)
  • TCRX 255.2K
  • SNT 38.8K
  • Earning Date
  • TCRX 08-12-2025
  • SNT 08-25-2025
  • Dividend Yield
  • TCRX N/A
  • SNT N/A
  • EPS Growth
  • TCRX N/A
  • SNT N/A
  • EPS
  • TCRX N/A
  • SNT 0.18
  • Revenue
  • TCRX $6,961,000.00
  • SNT $36,690,000.00
  • Revenue This Year
  • TCRX $159.20
  • SNT N/A
  • Revenue Next Year
  • TCRX N/A
  • SNT N/A
  • P/E Ratio
  • TCRX N/A
  • SNT $23.83
  • Revenue Growth
  • TCRX N/A
  • SNT 8.36
  • 52 Week Low
  • TCRX $1.02
  • SNT $1.40
  • 52 Week High
  • TCRX $6.23
  • SNT $5.04
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 54.34
  • SNT 52.10
  • Support Level
  • TCRX $1.60
  • SNT $4.20
  • Resistance Level
  • TCRX $1.86
  • SNT $4.40
  • Average True Range (ATR)
  • TCRX 0.10
  • SNT 0.24
  • MACD
  • TCRX 0.00
  • SNT 0.00
  • Stochastic Oscillator
  • TCRX 70.37
  • SNT 65.75

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About SNT Senstar Technologies Ltd.

Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.

Share on Social Networks: